My guess is because of CardioCel 3D..... All reports are that it's going fantastic and is going to be a big earner for Admedus although how big no one knows yet. By changing reporting time frame from FY18 to CY18 Wayne will be able to give a much more accurate and bigger guidance.... Also, India as well which will be a massive market for us.
All in all a great year for the company. Massively increased revenues, massively cut losses, brought in a group of amazing operators, revamped sales teams and infrastructure, launched 3 new products.... The next 12-18 months is going to be great, profitable and history making.
AHZ Price at posting:
28.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)